Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHRW | Common Stock | Options Exercise | $227K | +3.05K | +15.18% | $74.57 | 23.1K | Aug 25, 2022 | Direct | F1 |
transaction | CHRW | Common Stock | Sale | -$366K | -3.05K | -13.18% | $120.00 | 20.1K | Aug 25, 2022 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHRW | Stock Option (right to buy) | Options Exercise | $0 | -3.05K | -100% | $0.00* | 0 | Aug 25, 2022 | Common Stock | 3.05K | $74.57 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2022. |
F2 | Includes 109 shares acquired pursuant to the Issuer's employee stock purchase plan. |
F3 | Included in this amount are 19,951 shares of Issuer common stock issuable in settlement of an equal number of deferred shares and restricted stock units credited to the reporting person's NQDC Plan account. |
F4 | Fully vested. |